RecallRadar

FDA Device recall Z-3335-2026

Atellica CH Revised C-Reactive Protein (RCRP)

On 2026-10-07 the FDA classified a Class II recall of Atellica CH Revised C-Reactive Protein (RCRP) by Siemens Healthcare Diagnostics, citing the potential for falsely elevated results.

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-3335-2026
ClassificationClass II
Statusongoing
Initiated2026-08-17
Published2026-10-07
Last updated2026-10-13 05:30 UTC
CompanySiemens Healthcare Diagnostics
DistributionUS

Product

Atellica CH Revised C-Reactive Protein (RCRP); Siemens Material Number (SMN): 11537223;

Reason

The potential for falsely elevated results.

Identifiers

code_infoSiemens Material Number (SMN): 11537223; UDI-DI: 00630414610887; Lot numbers: All lots;

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-10-13 05:30 UTC. Current status: ongoing.

Other recalls by Siemens Healthcare Diagnostics

All Siemens Healthcare Diagnostics recalls

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-3335-2026%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.